These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


681 related items for PubMed ID: 22580627

  • 21. Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease.
    Bedair R, Babu-Narayan SV, Dimopoulos K, Quyam S, Doyle AM, Swan L, Gatzoulis MA, Wong T.
    Int J Cardiol; 2015 Feb 15; 181():218-24. PubMed ID: 25528316
    [Abstract] [Full Text] [Related]

  • 22. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I, Dekker RL, Jaarsma T, Strömberg A, Moser DK.
    J Psychosom Res; 2014 Aug 15; 77(2):122-7. PubMed ID: 25077853
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Age-specific differences in women with implantable cardioverter defibrillators: an international multi center study.
    Vazquez LD, Kuhl EA, Shea JB, Kirkness A, Lemon J, Whalley D, Conti JB, Sears SF.
    Pacing Clin Electrophysiol; 2008 Dec 15; 31(12):1528-34. PubMed ID: 19067804
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator.
    Cho EN, von Känel R, Marten-Mittag B, Ronel J, Kolb C, Baumert J, Ladwig KH.
    Heart; 2012 May 15; 98(10):806-12. PubMed ID: 22543838
    [Abstract] [Full Text] [Related]

  • 27. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators.
    DeMaso DR, Lauretti A, Spieth L, van der Feen JR, Jay KS, Gauvreau K, Walsh EP, Berul CI.
    Am J Cardiol; 2004 Mar 01; 93(5):582-7. PubMed ID: 14996583
    [Abstract] [Full Text] [Related]

  • 28. Psychological implications of ICD implantation in a New Zealand population.
    Newall EG, Lever NA, Prasad S, Hornabrook C, Larsen PD.
    Europace; 2007 Jan 01; 9(1):20-4. PubMed ID: 17224417
    [Abstract] [Full Text] [Related]

  • 29. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I, Moser DK, Strömberg A, Dekker RA, Chung ML.
    Europace; 2016 Jun 01; 18(6):828-35. PubMed ID: 26324839
    [Abstract] [Full Text] [Related]

  • 30. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life.
    Bostwick JM, Sola CL.
    Psychiatr Clin North Am; 2007 Dec 01; 30(4):677-88. PubMed ID: 17938040
    [Abstract] [Full Text] [Related]

  • 31. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator.
    Hoogwegt MT, Kupper N, Theuns DA, Jordaens L, Pedersen SS.
    Europace; 2012 Jan 01; 14(1):74-80. PubMed ID: 21920910
    [Abstract] [Full Text] [Related]

  • 32. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors.
    Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K.
    Pacing Clin Electrophysiol; 2006 Jun 01; 29(6):619-26. PubMed ID: 16784428
    [Abstract] [Full Text] [Related]

  • 33. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients.
    Johansen JB, Pedersen SS, Spindler H, Andersen K, Nielsen JC, Mortensen PT.
    Europace; 2008 May 01; 10(5):545-51. PubMed ID: 18378633
    [Abstract] [Full Text] [Related]

  • 34. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator.
    Luyster FS, Hughes JW, Gunstad J.
    J Cardiovasc Nurs; 2009 May 01; 24(1):10-7. PubMed ID: 19114795
    [Abstract] [Full Text] [Related]

  • 35. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.
    Undavia M, Goldstein NE, Cohen P, Sinthawanarong K, Singson M, Bhutani D, Munson T, Gomes JA, Fischer A, Mehta D.
    Pacing Clin Electrophysiol; 2008 Nov 01; 31(11):1411-8. PubMed ID: 18950298
    [Abstract] [Full Text] [Related]

  • 36. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator.
    Crössmann A, Schulz SM, Kühlkamp V, Ritter O, Neuser H, Schumacher B, Bauer W, Pauli P.
    Psychosom Med; 2010 Jun 01; 72(5):434-41. PubMed ID: 20410252
    [Abstract] [Full Text] [Related]

  • 37. Self-reported adjustment to implanted cardiac devices.
    Beery TA, Baas LS, Henthorn C.
    J Cardiovasc Nurs; 2007 Jun 01; 22(6):516-24. PubMed ID: 18090194
    [Abstract] [Full Text] [Related]

  • 38. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F, Foulldrin G, Savouré A, Anselme F, Baguelin-Pinaud A, Cribier A, Thibaut F.
    Gen Hosp Psychiatry; 2009 Jun 01; 31(3):266-73. PubMed ID: 19410106
    [Abstract] [Full Text] [Related]

  • 39. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator.
    Luyster FS, Hughes JW, Waechter D, Josephson R.
    Psychosom Med; 2006 Jun 01; 68(5):794-800. PubMed ID: 17012535
    [Abstract] [Full Text] [Related]

  • 40. [Impact of attachment style, social support and the number of implantable cardioverter defibrillator (ICD) discharges on psychological strain of ICD patients].
    Simson U, Perings C, Plaskuda A, Schäfer R, Brehm M, Bader D, Tress W, Franz M.
    Psychother Psychosom Med Psychol; 2006 Dec 01; 56(12):493-9. PubMed ID: 17160793
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 35.